- Home
- SNSE vs ZDAI Comparison
SNSE vs ZDAI Comparison
Compare SNSE & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- ZDAI
- Stock Information
- Founded
- SNSE 2005
- ZDAI 2022
- Country
- SNSE United States
- ZDAI Hong Kong
- Employees
- SNSE N/A
- ZDAI N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- Sector
- SNSE Health Care
- ZDAI Consumer Discretionary
- Exchange
- SNSE Nasdaq
- ZDAI Nasdaq
- Market Cap
- SNSE 14.5M
- ZDAI 14.8M
- IPO Year
- SNSE 2021
- ZDAI 2024
- Fundamental
- Price
- SNSE $9.10
- ZDAI $0.39
- Analyst Decision
- SNSE Strong Buy
- ZDAI
- Analyst Count
- SNSE 5
- ZDAI 0
- Target Price
- SNSE $72.50
- ZDAI N/A
- AVG Volume (30 Days)
- SNSE 77.5K
- ZDAI 2.2M
- Earning Date
- SNSE 11-07-2025
- ZDAI 11-18-2025
- Dividend Yield
- SNSE N/A
- ZDAI N/A
- EPS Growth
- SNSE N/A
- ZDAI N/A
- EPS
- SNSE N/A
- ZDAI N/A
- Revenue
- SNSE N/A
- ZDAI $19,275,673.00
- Revenue This Year
- SNSE N/A
- ZDAI N/A
- Revenue Next Year
- SNSE N/A
- ZDAI N/A
- P/E Ratio
- SNSE N/A
- ZDAI N/A
- Revenue Growth
- SNSE N/A
- ZDAI 43.16
- 52 Week Low
- SNSE $5.00
- ZDAI $0.37
- 52 Week High
- SNSE $18.35
- ZDAI $107.36
- Technical
- Relative Strength Index (RSI)
- SNSE 44.91
- ZDAI 33.26
- Support Level
- SNSE $8.33
- ZDAI $0.45
- Resistance Level
- SNSE $9.45
- ZDAI $0.57
- Average True Range (ATR)
- SNSE 1.00
- ZDAI 0.04
- MACD
- SNSE -0.27
- ZDAI -0.01
- Stochastic Oscillator
- SNSE 18.90
- ZDAI 8.03
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.